All Stories

  1. Hypopituitarism, Diabetes Insipidus, and Syndrome of Inappropriate Antidiuretic Hormone Secretion after Pituitary Macroadenoma Surgery with Indocyanine Green Dye

    Article • Diagnostics, August 2024, MDPI AG

    Tomaž Kocjan

  2. Subtype Identification of Surgically Curable Primary Aldosteronism During Treatment With Mineralocorticoid Receptor Blockade

    Article • Hypertension, June 2024, Wolters Kluwer Health

    Tomaž Kocjan

  3. Genome-wide association study identifies genetic variants which predict the response of bone mineral density to teriparatide therapy

    Article • Annals of the Rheumatic Diseases, July 2023, Elsevier

    Tomaž Kocjan

  4. International multicenter survey on screening and confirmatory testing in primary aldosteronism

    Article • European Journal of Endocrinology, January 2023, Oxford University Press (OUP)

    Tomaž Kocjan

  5. Detection and localization of hyperfunctioning parathyroid glands on [18F]fluorocholine PET/ CT using deep learning – model performance and comparison to human experts

    Article • Radiology and Oncology, December 2022, De Gruyter

    Tomaž Kocjan

  6. The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex – a multicenter-study of 3566 Caucasian and Asian subjects

    Article • European Journal of Endocrinology, September 2022, Oxford University Press (OUP)

    Tomaž Kocjan

  7. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study

    Article • The Lancet Diabetes & Endocrinology, July 2022, Elsevier

    Tomaž Kocjan

  8. Validation of three novel clinical prediction tools for primary aldosteronism subtyping

    Article • Endocrine Connections, May 2022, Bioscientifica

    Tomaž Kocjan

  9. Acromegaly: Clinical Care in Central and Eastern Europe, Israel, and Kazakhstan

    Article • Frontiers in Endocrinology, February 2022, Frontiers

    Tomaž Kocjan

  10. Feasibility of Imaging-Guided Adrenalectomy in Young Patients With Primary Aldosteronism

    Article • Hypertension, January 2022, Wolters Kluwer Health

    Tomaž Kocjan

  11. Switching to Denosumab or Bisphosphonates After Completion of Teriparatide Treatment in Women With Severe Postmenopausal Osteoporosis

    Article • Endocrine Practice, September 2021, Elsevier

    Tomaž Kocjan

  12. Limited diagnostic utility of partially successful adrenal vein sampling for primary aldosteronism subtyping

    Article • Endokrynologia Polska, August 2021, VM Media SP. zo.o VM Group SK

    Tomaž Kocjan

  13. Patients with Central Hypothyroidism are Less Sufficiently Treated with Levothyroxine than Patients with Primary Hypothyroidism

    Article • Experimental and Clinical Endocrinology & Diabetes, July 2021, Thieme Publishing Group

    Tomaž Kocjan

  14. Identification of Surgically Curable Primary Aldosteronism by Imaging in a Large, Multiethnic International Study

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2021, Endocrine Society

    Tomaž Kocjan

  15. Natural history of nonfunctioning adrenal incidentalomas: a 10-year longitudinal follow-up study

    Article • Endocrine Connections, June 2021, Bioscientifica

    Tomaž Kocjan

  16. Drug-resistant hypertension in primary aldosteronism patients undergoing adrenal vein sampling: the AVIS-2-RH study

    Article • European Journal of Preventive Cardiology, March 2021, Oxford University Press (OUP)

    Tomaž Kocjan

  17. ESE audit on management of adult growth hormone deficiency in clinical practice

    Article • European Journal of Endocrinology, February 2021, Oxford University Press (OUP)

    DAVIDE CARVALHO, Tomaž Kocjan

  18. Treatment of osteoporosis with teriparatide: The Slovenian experience

    Article • Open Medicine, January 2021, De Gruyter

    Tomaž Kocjan

  19. Adrenal Venous Sampling–Guided Adrenalectomy Rates in Primary Aldosteronism: Results of an International Cohort (AVSTAT)

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2020, Endocrine Society

    Tomaž Kocjan

  20. Adrenal vein sampling for primary aldosteronism: a 15-year national referral center experience

    Article • Radiology and Oncology, August 2020, De Gruyter

    Tomaž Kocjan

  21. Plasma levels of miR-30d-5p are decreased in regularly exercising postmenopausal women

    Article • Menopause, October 2019, Wolters Kluwer Health

    Tomaž Kocjan

  22. Clinical Outcomes of 1625 Patients With Primary Aldosteronism Subtyped With Adrenal Vein Sampling

    Article • Hypertension, October 2019, Wolters Kluwer Health

    Tomaž Kocjan

  23. 18F-Fluorocholine PET/CT in Primary Hyperparathyroidism: Superior Diagnostic Performance to Conventional Scintigraphic Imaging for Localization of Hyperfunctioning Parathyroid Glands

    Article • Journal of Nuclear Medicine, September 2019, Society of Nuclear Medicine

    Tomaž Kocjan

  24. Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2019, Endocrine Society

    Tomaž Kocjan

  25. Poti in stranpoti v diagnostiki primarnega aldosteronizma

    Article • Slovenian Medical Journal, March 2019, SZD - Slovenian Medical Association

    Tomaž Kocjan

  26. The Outcomes of Primary Aldosteronism Patients in the AVIS-2 Study

    Article • SSRN Electronic Journal, January 2019, Elsevier

    Tomaž Kocjan

  27. Strokovna stališča Združenja endokrinologov Slovenije o obravnavi glukokortikoidne osteoporoze

    Article • Slovenian Medical Journal, October 2018, SZD - Slovenian Medical Association

    Tomaž Kocjan

  28. Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism

    Article • Hypertension, September 2018, Wolters Kluwer Health

    Tomaž Kocjan

  29. Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism

    Article • Hypertension, September 2018, Wolters Kluwer Health

    Tomaž Kocjan

  30. Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS)

    Article • Calcified Tissue International, June 2018, Springer Science + Business Media

    Prof. Francisco Marin , Tomaž Kocjan

  31. Adrenal crisis after first infusion of zoledronic acid: a case report

    Article • Osteoporosis International, March 2018, Springer Science + Business Media

    Tomaž Kocjan

  32. Prevention Medicine in Bilateral Phaeochromocytoma

    Article • SSRN Electronic Journal, January 2018, Elsevier

    Tomaž Kocjan

  33. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort

    Article • The Lancet Diabetes & Endocrinology, September 2017, Elsevier

    Tomaž Kocjan

  34. Rational Approach to a Patient with Suspected Primary Aldosteronism

    Article • June 2017, IntechOpen

    Tomaž Kocjan

  35. Patterns in the Diagnosis and Treatment of Osteoporosis in Men: A Questionnaire-based Survey in Central and Eastern European Countries

    Article • Acta Medica Bulgarica, January 2017, De Gruyter

    Tomaž Kocjan

  36. Focused parathyroidectomy without intraoperative parathormone testing is safe after pre-operative localization with 18F-Fluorocholine PET/CT

    Article • European Journal of Surgical Oncology, January 2017, Elsevier

    Tomaž Kocjan

  37. MiR-148a the epigenetic regulator of bone homeostasis is increased in plasma of osteoporotic postmenopausal women

    Article • Wiener klinische Wochenschrift, November 2016, Springer Science + Business Media

    Tomaž Kocjan

  38. Outcome parameters in orthogeriatric co‑management – a mini-review

    Article • Wiener klinische Wochenschrift, November 2016, Springer Science + Business Media

    Tomaž Kocjan

  39. Incidence fracturaire, évolution des douleurs dorsales et de la qualité de vie de patients souffrant d’ostéoporose traités par le tériparatide : Résultats de l’étude Observationnelle Européenne ExFOS (Extended Forsteo® Observational Study)

    Article • Revue du Rhumatisme, November 2016, Elsevier

    Tomaž Kocjan

  40. A NEW CLINICAL PREDICTION CRITERION ACCURATELY DETERMINES A SUBSET OF PATIENTS WITH BILATERAL PRIMARY ALDOSTERONISM BEFORE ADRENAL VENOUS SAMPLING

    Article • Endocrine Practice, May 2016, AACE Corp (American Association of Clinical Endocrinologists)

    Tomaž Kocjan

  41. Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS)

    Article • Calcified Tissue International, April 2016, Springer Science + Business Media

    Tomaž Kocjan, Prof. Francisco Marin

  42. Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study

    Article • Journal of Ovarian Research, June 2015, Springer Science + Business Media

    Tomaž Kocjan

  43. Optimal scan time for evaluation of parathyroid adenoma with [18F]-fluorocholine PET/CT

    Article • Radiology and Oncology, January 2015, De Gruyter

    Tomaž Kocjan

  44. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome

    Article • HORMONES, January 2015, Springer Science + Business Media

    Tomaž Kocjan

  45. Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome

    Article • Endocrine Research, October 2014, Informa Healthcare

    Tomaž Kocjan

  46. Phosphodiesterase 4 Inhibition as a Potential New Therapeutic Target in Obese Women With Polycystic Ovary Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2014, Endocrine Society

    Tomaž Kocjan

  47. 18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study

    Article • European Journal of Pediatrics, July 2014, Springer Science + Business Media

    Tomaž Kocjan

  48. Study description and baseline characteristics of the population enrolled in a multinational observational study of extended teriparatide use (ExFOS)

    Article • Current Medical Research and Opinion, May 2014, Informa Healthcare

    Tomaž Kocjan

  49. Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin

    Article • December 2013, Bioscientifica

    Tomaž Kocjan

  50. Study description and baseline characteristics of the population enrolled in the extended forsteo[reg] observational study (ExFOS)

    Article • Bone Abstracts, May 2013, Bioscientifica

    Tomaž Kocjan

  51. Treatment of Hyperparathyroidism With Cinacalcet in Kidney Transplant Recipients

    Article • Transplantation Proceedings, December 2010, Elsevier

    Tomaž Kocjan

  52. Dihydrotachysterol intoxication treated with pamidronate: a case report

    Article • Cases Journal, January 2010, Springer Science + Business Media

    Tomaž Kocjan

  53. Analysis of Association of LRP5, LRP6, SOST, DKK1, and CTNNB1 Genes with Bone Mineral Density in a Slovenian Population

    Article • Calcified Tissue International, November 2009, Springer Science + Business Media

    Tomaž Kocjan

  54. APPROACH TO THE POSTMENOPAUSAL WOMAN WITH OSTEOPOROSIS IN SLOVENIA

    Article • Maturitas, May 2009, Elsevier

    Tomaž Kocjan

  55. The combinations of polymorphisms in vitamin D receptor, osteoprotegerin and tumour necrosis factor superfamily member 11 genes are associated with bone mineral density

    Article • Journal of Molecular Endocrinology, January 2009, Bioscientifica

    Tomaž Kocjan

  56. Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome

    Article • European Journal of Endocrinology, October 2008, Oxford University Press (OUP)

    Tomaž Kocjan

  57. Tumour necrosis factor superfamily member 11 gene promoter polymorphisms modulate promoter activity and influence bone mineral density in postmenopausal women with osteoporosis

    Article • Journal of Molecular Endocrinology, March 2008, Bioscientifica

    Tomaž Kocjan

  58. Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women

    Article • Menopause, March 2008, Wolters Kluwer Health

    Tomaž Kocjan

  59. Decreased Androgen Levels and Improved Menstrual Pattern after Angiotensin II Receptor Antagonist Telmisartan Treatment in Four Hypertensive Patients with Polycystic Ovary Syndrome: Case Series

    Article • Croatian Medical Journal, December 2007, Croatian Medical Journal

    Tomaž Kocjan

  60. Vitamin D Status in Patients with Osteopenia or Osteoporosis – an Audit of an Endocrine Clinic

    Article • International Journal for Vitamin and Nutrition Research, September 2006, Hogrefe Publishing Group

    Tomaž Kocjan

  61. Methimazole upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves’ disease

    Article • Journal of Endocrinological Investigation, April 2004, Springer Science + Business Media

    Tomaž Kocjan

  62. Hormone replacement therapy update: who should we be prescribing this to now?

    Article • Current Opinion in Obstetrics & Gynecology, December 2003, Wolters Kluwer Health

    Tomaž Kocjan

  63. Changes in Th1/Th2 cytokine balance in Graves’ desease

    Article • Pflügers Archiv - European Journal of Physiology, January 2000, Springer Science + Business Media

    Tomaž Kocjan